Abstract
[...]mirtazapine is one of the medications found useful in alleviating drug-induced akathisia and recommended in Parkinson's disease. [5] A recent study on a health database showed nearly 3.78 rate ratio of mirtazapine inducing extrapyramidal side effects with respect to age- and follow-up time-matched controls. Effect on the sensitive striatal alpha 2 adrenergic receptors in susceptible subjects could be the potential factor inducing movement-related adverse effects and may be an unusual phenotypic manifestation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Psychiatry, Iqraa International Hospital and Research Centre, Calicut, Kerala
2 Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka
3 Department of Medicine, Iqraa International Hospital and Research Centre, Calicut, Kerala
4 Department of Internal Medicine, Iqraa International Hospital and Research Centre, Calicut, Kerala